Bladder Cancer Survivor - Maria's Envita Review
After four rounds of unsuccessful treatments by three different doctors, Maria felt helpless as the symptoms of blood in her urine and kidney pain kept increasing. “No one had diagnosed what was going on,” said Maria Miller, who came to Envita Medical Centers, a world-class integrative center for precision oncology, for diagnosis and treatment of stage 2 bladder cancer.
Disclaimer: Individual results will vary. Envita makes no guarantees for outcomes. Each patient case is unique. Please consult your doctor before making any changes to your medical treatment. Not every patient is a candidate for care or achieves these results. Treatments used in this case may not all be FDA approved for the treatment of this condition.
Detailed Proprietary Tests
At Envita, we have developed several proprietary tests utilizing advanced technologies, such as Next Generation Sequencing (NGS), to gather a detailed genomic analysis of each individual patient. This in-depth genomic analysis is crucial for precision diagnosis, paving the way for developing a personalized and comprehensive treatment plan. “My bloodwork came back malignant,” said Maria, who found it difficult to accept her diagnosis, but was relieved to finally get the right diagnosis.
Reason for Choosing Envita
Maria had her tumors removed from the bladder at a different institution, but she was unwilling to follow their standard of care recommendation, which included bladder removal followed by chemotherapy and radiation. “I didn't want to go that route,” added Maria, which is why she chose to get treated at Envita. Our powerful combination treatments, like GTFC™ (Genetically Targeted Fractionated Chemotherapy) and personalized immunotherapies, are designed to effectively kill the cancer without compromising the patient's quality of life.
GTFC™ is our proprietary low-dose chemotherapy which maximizes the mechanisms of action against the cancerous cells without impacting the surrounding healthy cells. It is based on our detailed genomic analysis, which reveals the most suitable chemo agents with the highest chances of cancer kill for each individual patient. By utilizing metronomic dosage of targeted chemotherapy agents as opposed to standard maximum therapeutic dose untargeted chemotherapy, our team of integrative physicians are better prepared to attack each patient's cancer from all possible angles.
Advanced Personalized Immunotherapies
Along with GTFC™, our personalized immunotherapies have also proved beneficial for Maria. At Envita, we understand that our immune system is the first and last line of defense against cancer, which is why we include various levels of personalized immunotherapies in the treatment plan of all our patients, irrespective of their cancer type or stage.
Our innovative immunotherapies are designed to not only bolster the patient's immune system, but these therapies also train the immune system to identify early signs of cancer, effectively reducing chances of a recurrence. “I think Envita has a real goal to help patients. Not only do they value our lives, but they want to preserve our quality of life and that involved retaining my bladder,” said Maria, while reiterating how our ability to preserve her organ was one of the defining moments that led her to seek treatment here, at Envita.
Her Envita Connection
With our personalized treatment plan, Maria's cancer could be treated successfully without removing her bladder, and she thanks her health share company for recommending us. Solidarity health share covers certain tests and treatments at Envita, which is why they recommended us to Maria for an extensive bloodwork, when she had failed four rounds of antibiotic treatments. “Solidarity health share is sort of my insurance, but it's not an insurance... and they called me to see how I was doing,” said Maria, while explaining how their call was pivotal in guiding her to not only an accurate diagnosis, but a comprehensive treatment plan of her choice as well.
Call Us Today
The expert team at Envita includes oncologists, interventional radiologists, researchers, and pharmacists, who collaborate to design a unique treatment plan, aimed at improving patient quality of life, increasing longevity, and reducing toxicity. If you or any of your loved ones have questions regarding cancer, please feel free to call us at 866-830-4576.
